Cargando…

Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice

Non-alcoholic fatty liver disease (NAFLD) can progress to non-alcoholic steatohepatitis (NASH), characterized by inflammation and fibrosis. Fibrosis is mediated by hepatic stellate cells (HSC) and their differentiation into activated myofibroblasts; the latter process is also promoted by inflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Kyoung-Jin, Legaki, Aigli-Ioanna, Papadopoulos, Grigorios, Gercken, Bettina, Gebler, Janine, Schwabe, Robert F., Chavakis, Triantafyllos, Chatzigeorgiou, Antonios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002755/ https://www.ncbi.nlm.nih.gov/pubmed/36902241 http://dx.doi.org/10.3390/ijms24054813

Ejemplares similares

Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity
por: Moustakas, Ioannis I., et al.
Publicado: (2021)

Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
por: Legaki, Aigli-Ioanna, et al.
Publicado: (2022)

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2021)

No Role for Mast Cells in Obesity-Related Metabolic Dysregulation
por: Chmelař, Jindřich, et al.
Publicado: (2016)

Fate of Adipose Progenitor Cells in Obesity-Related Chronic Inflammation
por: Pyrina, Iryna, et al.
Publicado: (2020)

Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation
por: Karakousis, Nikolaos D., et al.
Publicado: (2023)

A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity
por: Chung, Kyoung-Jin, et al.
Publicado: (2017)

Hepatic Stellate Cell-Immune Interactions in NASH
por: Carter, James K., et al.
Publicado: (2022)

Adipocyte-Specific Hypoxia-Inducible Factor 2α Deficiency Exacerbates Obesity-Induced Brown Adipose Tissue Dysfunction and Metabolic Dysregulation
por: García-Martín, Rubén, et al.
Publicado: (2016)

Transcriptional regulation of Hepatic Stellate Cell activation in NASH
por: Marcher, Ann-Britt, et al.
Publicado: (2019)

Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?
por: Zisser, Alexandra, et al.
Publicado: (2021)

Cholesterol Induces Oxidative Stress, Mitochondrial Damage and Death in Hepatic Stellate Cells to Mitigate Liver Fibrosis in Mice Model of NASH
por: Rauchbach, Einat, et al.
Publicado: (2022)

Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation
por: Nagasaki, Atsuhiro, et al.
Publicado: (2020)

The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH—Future Horizons in NASH Management
por: Trifylli, Eleni-Myrto, et al.
Publicado: (2022)

Hematopoietic stem and progenitor cells take the route through the bone marrow endothelium
por: Kalafati, Lydia, et al.
Publicado: (2020)

Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
por: Hajishengallis, George, et al.
Publicado: (2021)

Inflammatory memory and comorbidities
por: Hajishengallis, George, et al.
Publicado: (2022)

sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH
por: Hall, Katherine C., et al.
Publicado: (2019)

Inhibition of 11β-hydroxysteroid dehydrogenase 1 relieves fibrosis through depolarizing of hepatic stellate cell in NASH
por: Lee, Su-Yeon, et al.
Publicado: (2022)

The Multifaceted Roles of Macrophages in NAFLD Pathogenesis
por: Vonderlin, Joscha, et al.
Publicado: (2023)

Leukocyte – endothelial interactions in inflammation
por: Langer, Harald F, et al.
Publicado: (2009)

Differentially expressed mRNAs and lncRNAs shared between activated human hepatic stellate cells and nash fibrosis
por: Gerhard, Glenn S., et al.
Publicado: (2020)

Phagocytosis of Apoptotic Cells in Resolution of Inflammation
por: Kourtzelis, Ioannis, et al.
Publicado: (2020)

Developmental endothelial locus-1 (Del-1) is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination
por: Choi, Eun Young, et al.
Publicado: (2014)

Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice
por: Koop, Anja Christina, et al.
Publicado: (2020)

A novel pathway of rapid TLR-triggered activation of integrin-dependent leukocyte adhesion that requires Rap1 GTPase
por: Chung, Kyoung-Jin, et al.
Publicado: (2014)

Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022)

The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018)

Hypoxia Pathway Proteins in Normal and Malignant Hematopoiesis
por: Wielockx, Ben, et al.
Publicado: (2019)

Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)
por: Subramanian, Pallavi, et al.
Publicado: (2022)

Nash vek /
por: Nappelʹbaum, Moisei Solomonovich, 1869-1958
Publicado: (1984)

Nash manifolds
por: Shiota, Masahiro
Publicado: (1987)

Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
por: Hirsova, Petra
Publicado: (2021)

Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis
por: Hayashi, Momoko, et al.
Publicado: (2023)

Functional knock down of VCAM1 in mice mediated by endoplasmatic reticulum retained intrabodies
por: Marschall, Andrea LJ, et al.
Publicado: (2014)

Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice
por: Yin, Liangqingqing, et al.
Publicado: (2022)

MiR-552-3p Regulates Multiple Fibrotic and Inflammatory genes Concurrently in Hepatic Stellate Cells Improving NASH-associated Phenotypes
por: Ma, Ningning, et al.
Publicado: (2023)

Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming
por: Pateras, Ioannis S., et al.
Publicado: (2023)

Enhanced Biosensor Platforms for Detecting the Atherosclerotic Biomarker VCAM1 Based on Bioconjugation with Uniformly Oriented VCAM1-Targeting Nanobodies
por: Ta, Duy Tien, et al.
Publicado: (2016)

From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
por: Gastaldelli, Amalia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5kdkkbbfnkn00q1f1fgqq3hkhl